OTC · Drug Manufacturers - Specialty & Generic

Australis Capital Inc. (AUSAF) Stock

$0.00 OTC: AUSAF Healthcare

Australis Capital Inc. functions as a cannabis enterprise, actively pursuing both cannabis and horticultural ventures.

Valuation

MetricValue
Price$0.00
Market Cap$2783
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-91.68%
ROA-16.62%
ROCE-48.49%
Gross Margin61.95%
Operating Margin-233.36%
Net Margin-625.00%
Debt/Equity0.05
Current Ratio0.69

Annual Financials (USD)

Metric20172018201920202021
Revenue$0$0$0$1.0M$8.0M
Operating Profit$0$-4.0M$-14.0M$-14.0M$-19.0M
Net Profit$0$-4.0M$-23.0M$-25.0M$-50.0M
EPS$0.00$-0.04$-0.14$-0.14$-0.16
Op Margin—-3309.2%-6500.8%-1957.0%-256.0%

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$3.0M$65.0M$64.0M$66.0M$51.0M
Total Liabilities$3.0M$4.0M$6.0M$13.0M$14.0M
Cash$0$6.0M$8.0M$3.0M$1.0M
Borrowings$3.0M$0$1.0M$2.0M$2.0M

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$0$-3.0M$-8.0M$-8.0M$-11.0M
Investing Cash Flow$0$-44.0M$-3.0M$-4.0M$11.0M
Financing Cash Flow$0$4.0M$2.0M$0$0
Net Cash Flow$0$6.0M$-8.0M$-13.0M$0
Free Cash Flow$0$-3.0M$-10.0M$-9.0M$-11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.13
FCF Yield-290261.90%
Quick Ratio0.63
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AYRWFAyr Wellness Inc. $0.00 — -0.03 $467094 0.00%
BUDZWEED, Inc. $0.02 -10.69% -2.35 $2.97M 0.00%
CBIHCannabis Bioscience International Holdings, Inc. $0.00 — -0.01 $1.74M 0.00%
DHBUFDelivra Health Brands Inc. $0.08 +13.29% -3.40 $2.59M 0.00%
FAGIFull Alliance Group, Inc. $0.01 +0.00% -4.72 $1.15M 0.00%

About Australis Capital Inc.

Australis Capital Inc. functions as a cannabis enterprise, actively pursuing both cannabis and horticultural ventures. These projects span a broad international landscape, encompassing the United States, Canada, Denmark, Finland, Iceland, Germany, the Netherlands, Bahrain, the United Arab Emirates, Southeast Asia, Australia, and numerous other global territories. The firm's corporate offices are located in Las Vegas, Nevada.

Australis Capital Inc. (AUSAF) stock trades at $0.00 with a market capitalization of $2783. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Australis Capital Inc. generates a return on equity (ROE) of -91.68%, return on capital employed of -48.49%, an operating margin of -233.36%, a net profit margin of -625.00%.

Official website: ausacap.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides